Nucleic acid-controlled catalytic rnas for trigger-responsive regulation
US-2024425855-A1 · Dec 26, 2024 · US
US9512428B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9512428-B2 |
| Application number | US-201514822099-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 10, 2015 |
| Priority date | Feb 21, 2012 |
| Publication date | Dec 6, 2016 |
| Grant date | Dec 6, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for producing mature hepatocytes having functional hepatic enzyme activity from human pluripotent cells is disclosed. The method includes the step of transferring an external vector comprising the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-122, the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-let-7c, a microRNA having the seed sequence of the microRNA miR-122, a microRNA having the seed sequence of the microRNA miR-let-7c, or a combination thereof into one or more fetal hepatocytes. The resulting cells differentiate into mature hepatocytes that exhibit functional hepatic enzyme activity, and can be used in drug metabolism and toxicity testing, in the study of viruses that target hepatic tissue, and as therapeutics. A related method of maintaining the functional hepatic enzyme activity of primary hepatocytes over time is also disclosed. The method includes the step of transferring an external vector comprising the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-122 into one or more cultured primary hepatocytes.
Opening claim text (preview).
We claim: 1. A culture comprising one or more isolated mature hepatocytes, wherein after nine days of culture, at least one of the hepatocytes maintains expression levels of tyrosine aminotransferase (TAT) that is at least 80% of the level that was exhibited when the culture was established, wherein the cells are expressing an exogenous sequence comprising (a) a first microRNA comprising a core sequence that is 18 to 24 nucleotides long, wherein the 10 nucleotide sequence on the 5′ end of the core sequence comprises a seed sequence consisting of any 6, 7, 8, 9 or 10 consecutive nucleotides of SEQ ID NO:5; or (b) an external vector comprising a DNA sequence coding for the first microRNA; or (c) a second microRNA comprising a core sequence that is 18 to 24 nucleotides long; wherein the 10 nucleotide sequence on the 5′ end of the core sequence comprises a seed sequence consisting of any 6, 7, 8, 9 or 10 consecutive nucleotides of SEQ ID NO:6; or (d) an external vector comprising a DNA sequence coding for the second microRNA; or (e) two or more of (a)-(d). 2. The culture of claim 1 , wherein the first microRNA comprises the nucleotide sequence of SEQ ID NO:2 or SEQ ID NO:1. 3. The culture of claim 1 , wherein the second microRNA comprises the nucleotide sequence of SEQ ID NO:4 or of SEQ ID NO:3.
Transferases (2) · CPC title
Liver; Hepatocytes · CPC title
Oxidoreductases (1) · CPC title
General methods applicable to biologically active non-coding nucleic acids · CPC title
MicroRNAs, miRNAs · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.